Synthesis of the β-hydroxydopa-γ-hydroxy-δ- sulfinylnorvaline component of ustiloxins a and B

Organic and Biomolecular Chemistry

Volumn 3, Issue 5, 2005, Pages 732-734

  Hunter, Luke ^a   McLeod, Malcolm D ^a   Hutton, Craig A ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; ALKYLATION; ALUMINUM COMPOUNDS; CATALYSIS; CHEMICAL MODIFICATION; ISOMERS; OXIDATION; REACTION KINETICS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ANTIMITOTIC AGENTS; STEROSELECTIVITY; SULFINYLINORVALINE SYNTHESIS; SULFOXIDES;

AROMATIC COMPOUNDS;

BENZALDEHYDE DERIVATIVE; CYCLOPEPTIDE; DOPA; DRUG DERIVATIVE; ISOVANILLIN; MYCOTOXIN; NORVALINE; SULFIDE; SULFOXIDE; USTILOXIN A; USTILOXIN B; VALINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; OXIDATION REDUCTION REACTION; SYNTHESIS;

BENZALDEHYDES; DIHYDROXYPHENYLALANINE; MOLECULAR STRUCTURE; MYCOTOXINS; OXIDATION-REDUCTION; PEPTIDES, CYCLIC; SULFIDES; SULFOXIDES; VALINE;

EID: 15244350598     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b418876d     Document Type: Article

References (23)

1. (a) Y. Koiso, M. Natori and S. Iwasaki, Tetrahedron Lett., 1992, 33, 4157;
2. (b) Y. Koiso, M. Natori, S. Iwasaki, K. Hanaoka, T. Kobayashi, R. Sonoda, Y. Fujita, H. Yaegashi and Z. Sato, J. Antibiot., 1994, 47, 765.
3. (a) R. F. Luduena, M. C. Roach, V. Prasad, M. Banerjee, Y. Koiso, Y. Li and S. Iwasaki, Biochem. Pharmacol. 1994, 47, 1593;
4. (b) N. Morisaki, Y. Mitsui, Y. Yamashita, Y. Koiso, R. Shirai, Y. Hashimoto and S. Iwasaki, J. Antibiot., 1998, 51, 423.
5. B. Cao, H. Park and M. M. Joullié, J. Am. Chem. Soc., 2002, 124, 520.
6. (a) A. M. Sawayama, H. Tanaka and T. J. Wandless, J. Org. Chem., 2004, 69, 8810;
7. (b) H. Tanaka, A. M. Sawayama and T. J. Wandless, J. Am. Chem. Soc., 2003, 125, 6864.
8. D. A. Evans, J. M. Janey, N. Magomedov and J. S. Tedrow, Angew. Chem., Int. Ed., 2001, 40, 1884.
9. Ar = p-methoxyphenyl.
10. C. A. Hutton and J. M. White, Tetrahedron Lett., 1997, 38, 1643.
11. (a) K. O. Hessian and B. L. Flynn, Org. Lett., 2003, 5, 4377;
12. (b) J. A. Schwartz, Synth. Commun., 1986, 16, 565.
13. R. E. Bolton, C. J. Moody, C. W. Rees and G. Tojo, J. Chem. Soc., Perkin Trans. 1, 1987, 931.
14. (a) M. C. Munson, C. Garcia-Echeverria, F. Albericio and G. Barany, J. Org. Chem., 1992, 57, 3013;
15. (b) C.-E. Lin, S. K. Richardson and D. S. Garvcy, Tetrahedron Lett., 2002, 43, 4531.
16. S. Vetter, Synth. Commun., 1998, 28, 3219.
17. (a) L. Lemoucheux, J. Rouden, M. Ibazizene, F. Sobrio and M.-C. Lasne, J. Org. Chem., 2003, 68, 7289;
18. (b) P. R. Dave, K. A. Kumar, R. Duddu, T. Axenrod, R. Dai, K. K. Das, X.-P. Guan, J. Sun, N. J. Trivedi and R. D. Gilardi, J. Org. Chem., 2000, 65, 1207;
19. (c) R. G. Bhat, Y. Ghosh and S. Chandrasekaran, Tetrahedron Lett., 2004, 45, 7983;
20. (d) M. W. Miller, S. V. Vice and S. W. McCombie, Tetrahedron Lett., 1998, 39, 3429;
21. (e) H. Kapnang and G. Charles, Tetrahedron Lett., 1983, 24, 3233.
22. (a) W. C. Lumma, Jr., G. A. Dutra and C. A. Voeker, J. Org. Chem., 1970, 35, 3442;
23. (b) J. A. Levine, J. A. Ferrendelli and D. F. Covey, J. Med. Chem., 1986, 29, 1996.